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Practice Points 
 Professionals may feel reluctant to initiate discussions about secondary progressive 
disease and may defer the conversation because of uncertainty about the stage of 
disease and how to discuss the transition.  
 Routinely discussing the possibility of progression or asking patients to perform self-
assessments of their own condition may facilitate this discussion. 
 Providing psychological support and promoting self-management are important but 
hard to achieve. Upskilling professionals in these areas may improve future patient 
care.  
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Abstract 
Background: Identifying the transition from relapsing-remitting to secondary progressive 
multiple sclerosis (SPMS) can be challenging for clinicians. Little previous research has 
explored how professionals experience working with patients during this specific stage of the 
disease. We explored the experiences of a group of multidisciplinary professionals who 
support patients in the transition to SPMS, to describe this stage from a professional 
perspective.  
Methods: Qualitative semistructured interview study with 11 professionals (medical, 
nursing, and allied professionals; both specialists and generalists) working with patients with 
MS in South Wales, United Kingdom. Thematic analysis of the interview data was 
performed. 
Results: Two overarching themes were identified: the transition and providing support. The 
theme “transition” comprised issues related to recognizing and communicating about SPMS. 
Uncertainty influenced both recognizing the transition and knowing how to discuss it with 
patients. “Providing support” included descriptions of challenging aspects of patient care, 
providing support for carers, utilizing the multidisciplinary team, and working within service 
constraints. Providing adequate psychological support and engaging patients with self-
management approaches were seen as particularly challenging.  
Conclusions: Caring for patients in the transition to SPMS generates specific challenges for 
professionals. Further research on health-care interactions and patients’/professionals’ 
experiences around the transition phase may help to identify strategies for professional 
development and learning, and how to optimize patient experience at this difficult stage of 
disease.  
 
 
www.ijmsc.orgInternational Journal of MS Care Preprint
Pr
ep
rin
t
4 
 
INTRODUCTION 
Multiple sclerosis (MS) is the most common disabling neurologic condition affecting young 
adults,
1
 but little research to date has specifically examined professionals’ experiences of 
identifying and managing the transition to secondary progressive MS (SPMS). Most patients 
are diagnosed with relapsing-remitting disease, but as time progresses, most will transition to 
secondary progressive MS.
1
 SPMS is defined retrospectively once a sustained period of 
worsening neurologic impairment has been established over at least 6 to 12 months.
2
 
However, applying this diagnosis in clinical practice is challenging and often results in a 
period of diagnostic uncertainty.
3
 Sand and colleagues showed that the time taken from 
clinicians’ first recording the possibility of progression to actually definitively labeling SPMS 
was on average nearly 3 years.
3
 Professionals can interpret disease progression as a personal 
defeat for which they feel responsible.
4
 No biological markers or imaging methods are 
available to definitively predict disease course,
5
 which may result in true diagnostic 
uncertainty.
3
 Discussing this uncertainty with patients takes clinicians’ time and emotional 
energy.
6
 In the United Kingdom it is recommended that disease-modifying agents (DMAs) be 
stopped once established nonrelapsing progressive disease is confirmed.
7
 Confirming the 
transition and stopping DMAs may also result in the patient being reviewed less frequently 
by a neurologist, and transferred to nurse-led rather than neurologist-led follow-up. 
Clinicians’ awareness of these issues and the potential resultant patient anxiety may act as a 
further barrier to timely discussion.
3
 
We aimed to explore in depth the experiences of both specialists and generalists 
working with patients in the transition stage. We were interested in how clinicians addressed 
the transition with their patients and how they provided support throughout this phase. As 
self-management strategies are advocated for people with MS dealing with the impact of their 
symptoms,
8
 we also explored how professionals currently promoted self-management. Data 
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exploring patient and carer perspectives of the transition to SPMS are reported elsewhere.
9
 
The aim was to inform future research and development of strategies for professional 
development and learning, in order to optimize patient experience at this difficult stage of 
disease. 
 
METHODS 
Participants 
 The advisory group members developed a sampling frame, based on their experience 
of multidisciplinary team involvement in patient care during the transition phase. We planned 
to interview three MS specialist nurses, two neurologists, and one of each of the following 
professionals: occupational therapist, physiotherapist, neuropsychologist, general practitioner, 
community nurse, social worker. MS specialist nurses and neurologists represented nearly 
half of the proposed sample due to regularly working with patients in the transition and their 
depth of experience in the area. All professionals were recruited from South Wales (enabling 
face-to-face interviews) across three different University Health Board areas offering 
neurology services. Professionals working locally in the above roles were identified using 
contacts of the advisory group members. There was a limited pool of potential participants 
from certain professional groups within the local area, making it inevitable that many of the 
participants would be known to the advisory group members, but this sampling approach 
enabled rapid recruitment and generated a good participation response. Participants were 
made aware that the study was commissioned by an MS charity and that results would be 
anonymized prior to any reporting. Participants were aware of the researcher’s (FD) 
background as a university-based academic general practitioner. No participants were known 
to the researcher before involvement in the study. We recognized that being interviewed by a 
fellow health professional might facilitate or inhibit certain participant responses.
10 
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Setting 
The participants all work in South Wales, United Kingdom. Multiple sclerosis 
services in this area are provided by the publicly funded National Health Service. Secondary 
care services are led by consultant neurologists, and all patients have access to advice and 
support from a secondary care–based MS specialist nurse. Patients also have access to allied 
health professionals who may operate specialist or generalist services. Community services 
including general practitioners (primary-care physicians), community nurses (for people 
requiring nursing care at home), and social workers also contribute to care provision. These 
community providers may not have any specialist knowledge of MS.  
 
Data Collection 
The project was approved by the South East Scotland Research Ethics Committee 01 
(REC reference: 13/SS/0160). Qualitative semistructured interviews were conducted with 
health professionals to explore their experiences of working with people in the transition to 
SPMS.
11
 The semistructured interview guide (summarized in Table 1) was developed 
iteratively with input from members of the multidisciplinary study advisory group, which 
included a patient representative. The questions were developed through discussion and based 
on the advisory group members’ experience and knowledge of the existing literature. All 
participants provided written informed consent. Interviews were performed by author FD in a 
quiet room at the professionals’ workplaces.  
 
Analysis 
Interviews were audio-recorded and transcribed verbatim by professional transcribers. 
Transcripts were analyzed using inductive thematic analysis as described by Braun and 
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Clarke.
12
 Following data immersion, a codebook was generated by FD and codes applied to 
the transcripts using the software NVivo 10 (QSR International). Once all interview 
transcripts were coded, FD began the process of identifying candidate themes, which were 
then discussed with author FW (who was also familiar with the data) and subsequently 
refined. The findings from the preliminary data analysis were also summarized and circulated 
to the participants by e-mail for comment and validation. This exercise suggested that the 
emerging findings were credible to the participants. The data were reviewed by FD to ensure 
that the refined themes were representative, and the themes were named collaboratively (FD 
and FW). The researchers have differing professional backgrounds (FD as a clinician, FW as 
a social scientist) and brought their differing perspectives to the analysis. The sample size 
was too small to reach theoretical saturation within each professional group, although there 
was consensus across the differing groups on many of the issues discussed.  
 
RESULTS  
Three professionals did not respond to the e-mail invitation, so alternative participants 
were approached. Ten participants were recruited via e-mail. One further professional was 
recruited via an invitation from another participant. The participant characteristics are shown 
in Table 2. Interviews lasted between 20 and 52 minutes. 
Two overarching themes were identified: the transition and providing support. The 
themes and associated subthemes are shown in Table 3, together with the initial open codes to 
which they relate. Illustrative quotations are provided throughout the results section below. 
To help maintain anonymity for our respondents, quotations are labeled as coming from one 
of three subgroups (medical, nursing, or allied health professional). 
  
Theme 1: The Transition 
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Recognition  
The transition to SPMS is a retrospective diagnosis, and this meant that recognizing 
the transition took time and often required repeated assessments: “It takes a while to know for 
definite if they are in transition” (Participant 33; nursing). Professionals described that 
continuity of care helped them feel more confident about reaching the diagnosis. Conversely, 
the lack of an objective test could cause uncertainty that resulted in a tendency to delay 
discussion: “That’s part of our anxiety I think about the uncertainty because we can’t stick 
them in the MRI scanner and have a result from [radiologist] saying this person is now 
progressive” (Participant 14; medical). 
When faced with possible diagnostic error, clinicians usually waited for the situation 
to evolve before confirming SPMS. One clinician described giving patients the “benefit of the 
doubt” (HP34) in this situation before considering discontinuing disease-modifying 
medication. Clinicians recognized that the uncertainty of the situation could be difficult for 
their patients and that accepting disease progression was sometimes challenging for clinicians 
themselves. Some professionals shared their uncertainty about prognosis with their patients, 
while others dealt with the uncertainty by deferring the discussion.  
Although diagnosing the transition was seen as the role of neurologists and specialist 
nurses, the allied professionals described that if they felt that patients’ disease course had 
changed, they would encourage patients to reflect on their own situations and come to their 
own conclusions: “Those sort of decisions are best discussed, made with a consultant, saying 
you are secondary […] [we] perhaps try and sort of plant the seed a bit. So I’d maybe say to a 
patient, ‘Well, listen, 2 years ago, you could walk for an hour at a time, now you’re only 
walking for ten minutes, do you think things have changed?’” (Participant 9; allied 
professional). 
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There were differing views about how equipped patients were to interpret their own 
changing symptoms. Some suggested that although patients might recognize a deterioration 
in their symptoms, they did not always have the necessary knowledge to interpret this 
deterioration as a sign of the transition, and required professional support to understand the 
meaning of the changes they experienced: “I think patients don’t understand necessarily that 
relapsing-remitting MS is likely to change into secondary progressive MS” (Participant 35; 
nursing). Others suggested that patients probably knew “deep down” that their MS was 
worsening but were not ready to accept this and that this denial prevented full recognition of 
the transition.  
 
Communication  
 Broaching the Subject. Professionals described the value of having an open dialogue 
about SPMS with patients as an important move away from the medical paternalism of the 
past. They recognized that discussing SPMS in a timely fashion allowed their patients to 
prepare for their future. However, despite recognizing the importance of this open 
communication, initiating the conversation remained challenging. Professionals reported that 
patients rarely raised the subject of the transition themselves, so professionals struggled to 
know when they should tackle the issue: “It is very difficult when someone is relapsing to 
talk the sort of doom and gloom, what might happen to you however many years down the 
line because MS is so unpredictable isn’t it, you can’t be certain what’s going to happen to 
them” (Participant 14; medical). 
Professionals felt that it was probably inappropriate to discuss SPMS soon after 
diagnosis when it may be of limited current relevance to patients, but equally felt that when 
the transition was imminent it was probably too late. There was an overall feeling that some 
patients were left unprepared for the possibility of secondary progression: “Because we don’t 
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prepare them. [INT: No?] Not until we are asked by them mostly. [INT; Yeah, yeah if they do 
that.] Yeah if they bring it up, I wouldn’t necessarily sit down and say ‘alright, you know 4 
months now after your relapse, we keep an eye on this because possibly you are getting 
secondary’” (Participant 33; nursing). 
When professionals did feel it was appropriate to broach the subject, finding a way to 
communicate the news empathically could be stressful: “It’s trying to word it without 
frightening them, like the booklets [say], ‘they accumulate disability slowly over time,’ well 
that sounds good, but not when you’re trying to tell someone that” (Participant 32; nursing). 
Generally professionals described more difficulties with raising the topic themselves, 
whereas responding to patients’ queries or concerns was seen as much easier. Professionals 
also described that patients’ interest in receiving information about their condition could be 
highly variable: “Some people need lots, some people don’t want any, some people really 
don’t want to know but […] you have to tailor it to the individuals I think” (Participant 40; 
medical). 
 Dealing with the Response. The emotional impact of the confirmation of SPMS 
weighed heavily on the minds of practitioners, making the discussion sometimes more 
difficult. A spectrum of different coping reactions to SPMS was recognized, from acceptance 
as a natural progression to triggering a significant emotional response: “What I see in clinic 
is, like, a shrug of the shoulders or, it is what it is, so there’s kind of that resignation to that” 
(Participant 26; allied professional). Specialists recognized that when patients were already 
dealing with increasing disability, discontinuation of treatment was difficult to manage, 
especially as they felt it could lead to a sense of abandonment among their patients. Denial, 
panic, and a sense of loss were other frequently encountered reactions. 
 Strategies Employed. Professionals described how continuity of care allowed them 
to get to know their patients and to better judge how and when to provide information. 
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Warning shots and hints were sometimes used to try to raise awareness of possibility of 
transition when professionals became suspicious that it might be happening. To counter the 
“worst case scenario” thinking that patients often expressed after hearing their disease course 
had changed, the professionals described trying to frame the transition to SPMS in a positive 
light. They tried to emphasize the possibility that decline of function might be very slow and 
focused on the support services available. A few described taking a proactive approach, 
finding it easier to discuss the possibility of transition routinely before it became relevant as a 
way of raising awareness for the potential for disease course to change: “I talk about the 
stopping criteria even if they are nowhere near it so that they understand that progressive 
disease may well come along in the future” (Participant 34; medical). 
Some professionals explained how their working practices had facilitated a more open 
approach to discussing SPMS. One nurse described using a pre-clinic questionnaire 
completed by patients (which included a question about a perceived worsening of symptoms 
not related to relapses) as a way of opening the conversation about current disease stage. The 
practice of sending patients copies of clinic letters also made clinicians more mindful of 
ensuring that the content did not come as a surprise to patients. Written information was 
recognized as extremely useful for patients, although participants did not routinely provide 
literature about the transition. Often this was due to a lack of suitable resources available at 
hand, although even if resources were available, sometimes professionals felt it was the 
wrong moment at which to provide potentially upsetting information.  
 
Theme 2: Providing Support 
 As well as the difficulties surrounding identifying and discussing the transition, 
professionals described additional clinical and organizational challenges throughout the 
transition phase.  
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Challenging Aspects of Patient Care 
 Most professionals were involved to some extent in symptom management, with some 
symptoms described as more difficult to manage than others. In general, invisible symptoms 
such as changes in mood, memory, and personality were seen as more challenging, as 
professionals often felt they lacked the necessary skills and resources to manage these 
effectively: “I don’t have that expertise. I can try and take them through some initial sort of 
steps and suggestions, but at the end of the day I’m not a trained counselor” (Participant 35; 
nursing). Professionals recognized that often their own ability to provide adequate 
psychological support was limited and were then further frustrated that there was limited 
provision for more formal psychological support within the health-care system. Recognition 
of the wider social impact of cognitive symptoms increased the professionals’ dissatisfaction 
with what they were able to offer: “What has such a significant impact on social relationships 
and everything else is the cognitive side of things, so people find it very distressing when, 
okay, physical adaptations can be made in the work environment to sustain employment; 
however, when you start noticing yourself that you’re just not able to do things the way that 
you could before, that becomes very, very distressing” (Participant 26; allied professional). 
            Although symptoms such as spasticity and fatigue could also be very difficult, 
clinicians preferred dealing with situations where there was opportunity for them to feel they 
were doing something active: “If you offer them a tablet, then somehow that helps you feel 
better at least” (HP34). Staff often expressed frustration with the challenge of promoting 
patient engagement, perceiving that the advice they provided was sometimes met with apathy 
or resistance: “Some people you can sort of keep on about things, you need to do this, and 
you need to do this, and it is like hitting a brick wall” (Participant 9; allied professional). 
 Patients’ difficulties with low mood, cognition, and fatigue were all recognized as 
barriers to effective self-management. Professionals generally agreed that self-management 
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did not appeal to all patients. It was difficult to encourage these patients to take control 
themselves rather than to defer the responsibility to the professionals. Some described that 
although they felt they should do more to encourage self-management, they sometimes 
instinctively tried to help patients by doing things for them instead: “I think a bit like a 
doctor, writing a prescription you feel you want to do something for somebody and it is not 
always the right thing […] I probably ought to signpost people more instead of doing it all 
myself” (Participant 15: allied professional). Professionals often described that once they had 
provided the patient with the required information, it became the patient’s choice how they 
used this information: “You know we can give them all the tools but if they are not motivated 
for whatever reasons they are, no, you know it’s not going to help them” (Participant 33; 
nursing). 
Professionals often appeared to lack specific strategies to help support self-
management in more challenging situations. When self-management did work well, 
professionals observed that it could help patients feel in control while discouraging excessive 
reliance on professional support. Concerns about patients receiving too much “upsetting 
information” could lead health professionals to discourage certain activities, such as joining 
support groups, although they had also seen some patients benefit from sharing their 
experiences with others. Although none of the professionals interviewed had received any 
specific self-management support training, most viewed it as a natural part of patient care: 
“That’s the whole philosophy, really. You need to try and work in partnership with a person 
and let them make the decisions, as long as they’ve got the capacity” (Participant 41). 
 
Supporting Carers 
Professionals recognized the important role of carers and the burden associated with 
being a carer: “My whole attitude with all family members, is that if they’re not supported, it 
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doesn’t work” (Participant 43; nursing). Professionals described carers’ reluctance to request 
support for themselves, and reported that in some cases, carers actively resisted support. 
Support for carers was often largely described as services such as respite care and “sitting,” 
which would not become necessary until carers were taking on a greater role in providing 
physical care. Providing the other types of practical and emotional support that might be 
more important around the transition phase appeared to require either a direct request from 
the carer or for the professional to detect difficulties if carers happened to attend patients’ 
routine appointments. Although professionals tried to identify carers’ difficulties where 
possible, they recognized with some frustration that even if problems were identified there 
was a limited amount they could actually offer due to limited resources: “Well, we always 
ask how they’re managing at home and if they’re coping but that’s about it” (Participant 32; 
nursing). 
 
Working with Others 
Multidisciplinary working was important to all professionals interviewed. The 
valuable expertise that colleagues could provide was recognized as beneficial to both 
professionals and patients: “I don’t think you can do it on your own. If it’s just me in a clinic 
on my own it wouldn’t work. I need the nursing staff, and the OT and the physio” 
(Participant 14; medical). Referrals to other members of the team appeared to occur for 
different reasons. Professionals described recognizing the limitations of their own expertise 
and feeling that the input of others would improve patient care. There were also suggestions 
that limited time and workload pressures could prompt professionals to delegate to others 
rather than taking personal responsibility for certain elements of patient care.  
 
Service Constraints  
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Professionals wanted to be able to provide more services but were limited in what 
they could achieve due to time and service constraints. Having the time to develop a 
relationship with their patients improved the support professionals felt they could offer, but 
high workloads acted as barriers: “The caseloads are too big to give people enough time and 
attention” (Participant 41; allied professional). Professionals felt that having more time 
available would facilitate continuity of care and allow some patients’ difficulties to be pre-
empted before they occurred. This more continuous model of care was suggested as a way to 
ensure patients received the right help at the right time, potentially avoiding patients reaching 
crisis points before seeking support. Early SPMS was suggested as the right time to target 
patients for more intensive follow-up and support. However, it was recognized that individual 
support needs and preferences varied widely. Professionals aspired to see services tailored to 
incorporate more elements of choice and flexibility to meet individuals’ personal 
requirements. 
 
DISCUSSION 
This exploratory work has described the experiences of the transition from the 
perspectives of a small group of multidisciplinary health professionals who regularly work 
with people with MS and their carers. The transition can only be identified over time. 
Professionals often felt unsure about when first to mention SPMS and recognized that they 
might be leaving their patients unprepared. Apprehension about discussing the transition was 
described because of the potential for a negative reaction. Managing “invisible” symptoms 
and providing adequate psychological support were ongoing challenges, especially within the 
constraints of the service described.  
 
Strengths and Limitations 
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A range of different professionals involved in patient care were included in the study, 
and considerable variation in attitudes and in current practices toward addressing the 
transition with patients was identified. The qualitative approach supported a more in-depth 
understanding of the complexity of working at this stage than would have been possible using 
a quantitative method. Although confirming the transition was generally a concern for 
neurologists and MS nurses, the other themes were well represented across the specialist and 
generalist participants. Data analysis was performed collaboratively and participant validation 
suggested that the emerging themes had strong credibility. All participants worked in a single 
geographic area, and we recognize that the challenges described may be specific to the local 
context. The small sample may have resulted in a failure to capture the full range of varying 
viewpoints that exist. Additional data from each professional group would have also allowed 
the relative importance placed on different issues to be assessed.  
 
Putting Our Findings into Context 
The challenges our participants described around confidently identifying the transition 
to SPMS appear to be reflected in previous quantitative research, suggesting that the 
confirmation of SPMS can take several years.
3
 Bamer et al.
5
 found that people with MS were 
more likely to classify themselves as progressive compared to physician evaluators. Our 
complementary qualitative research showed that some patients felt they had transitioned to 
SPMS without the issue having being directly discussed at a consultation.
9
 In other settings, 
as in this study, clinician discomfort with delivering negative or uncertain diagnoses and 
prognoses has been described.
13,14
 This discomfort may decrease the clarity of information 
clinicians provide to patients.
15
 Consultation observations have shown neurologists do not 
regularly assess patients’ preferences for information provision around the time of 
diagnosis.
16
 The medical model of care predominated in the way participants in this study 
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addressed the issue of the transition with their patients, with some professionals describing 
making decisions on their patient’s behalf about when they might be ready to take on board 
information. In other cases professionals seemed to wait for patients to ask questions rather 
than initiating the discussion themselves. People with MS have described that they do not 
want to be protected from troubling possibilities.
17
 It may be that some patients would prefer 
to be kept fully informed around the transition but that professionals are not sufficiently 
recognizing this desire. From a professional perspective it seems that deferring the discussion 
is used to improve diagnostic certainty and help facilitate a gradual recognition of changing 
symptoms among their patients. However, for patients who are experiencing changing 
symptoms, this may add to confusion and uncertainty around how SPMS is diagnosed and 
what it means for them as an individual.
9
 Our work exploring the transition to SPMS from the 
patient perspective showed that people with MS wanted clarification of what having SPMS 
meant for them, reassurance about how they would be supported by the health-care team, and 
self-help information.
9
 A move to a more proactive patient-centered model of care whereby 
information needs are actively assessed and addressed might improve transition care, 
although this still represents a major culture shift for some professionals. 
The challenges of managing invisible symptoms such as cognitive impairment and 
fatigue and of providing psychosocial support identified in our interviews have also been 
described elsewhere.
18,19
 Patients’ psychological well-being and fatigue are also recognized 
barriers to engaging with self-management approaches. Future continuing professional 
development activities for professionals working with patients in the transition to SPMS 
could include training in psychological techniques promoting positive coping, which has been 
trialed with some success elsewhere.
20,21
 Supporting self-management in this patient group is 
challenging, and professionals may need help to develop advanced facilitation skills.  
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The development of new biomarkers
22
 and clearer diagnostic criteria for the transition 
to SPMS may in future help to alleviate some clinician uncertainty about whether the label of 
SPMS should be confirmed. However, the challenges of dealing with the emotional impact of 
the transition will remain. Further research across a range of settings and with greater 
numbers of participants from each professional group is required to understand whether the 
challenges described here are common to health professionals working elsewhere. Although 
much research has explored how to improve communication around the diagnostic stage,
23
 
the transition to SPMS has previously been largely overlooked. Our research suggests that it 
may be important to further explore how and when clinicians choose to broach the subject of 
SPMS and how this can be better facilitated given both the variation in practice and the 
difficulties professionals described. Gathering data about patients’ perspectives on their 
preferences around discussing disease progression could helpfully inform health 
professionals. Exploring how differing working practices and service delivery models might 
facilitate or inhibit the provision of high-quality care around the transition would also be 
useful to inform service design.  
 
CONCLUSION  
The transition to SPMS is a diagnostic challenge for professionals, which in turn 
makes communicating with patients at this time difficult. Some professionals felt they lacked 
all of the skills that could be useful in supporting patients through the transition, particularly 
in relation to psychological support and self-management. Although multidisciplinary 
working provides great support for professionals, they remain frustrated by service 
constraints. Our data suggest that health-care interactions and patients’/professionals’ 
experiences around the transition to SPMS should be researched further, as a basis for 
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identifying strategies for professional development and learning, and how to optimize patient 
outcomes and experiences at this difficult stage of disease. 
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Table 1. Interview guide summary  
A: Experiences of working with people during the transition 
What is your experience of working with patients in the transition between relapsing-
remitting and secondary progressive MS? 
Which symptoms do you find most difficult to help patients to manage? 
B: Sources of information and support provided 
What support do you routinely offer to patients and carers to help them cope with MS? 
How do you think the support available for patients and carers could be improved?  
C: Changing support needs 
Are you involved in identifying or discussing the transition to secondary progressive MS? 
Can you tell me about your experiences of this?  
Are there any particular challenges in discussing the transition with patients? 
What support or education for clinicians would make supporting patients at the transition 
phase easier? 
D: Self-management  
Could you describe any ways in which you try to help your patients to self-manage their 
condition? 
How do the patients respond?  
Have you had any specific training on the subject? 
What do you think would help health professionals to promote self-management among 
patients in the transition phase in MS? 
What sort of education do you think health professionals would find most useful in order to 
improve their skills in promoting self-management among patients? 
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 Table 2. Health professional characteristics 
Role Gender Time in 
current 
role 
Frequency of 
contact with 
MS patients 
Role descriptor 
for 
anonymization 
Consultant neurologist 
(MS specialist) 
 
M 6 years Daily Medical 
Consultant neurologist 
(rehabilitation) 
 
F 6 years Weekly Medical 
GP principal and associate 
specialist in neurology 
 
M 10 years Monthly Medical 
MS specialist nurse 
 
F 2 years Daily Nursing 
MS specialist nurse 
 
F 12 years Daily Nursing 
MS specialist nurse  
 
F 10 years 2–3 times a 
week 
Nursing 
Community nurse 
 
F 42 years 2–3 times a 
week 
Nursing 
Neurophysiotherapist 
 
F 12 years Daily Allied 
professional 
Occupational therapist— 
neurologic conditions 
F 4 months 2–3 times a 
week 
Allied 
professional 
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Clinical neuropsychologist 
 
F 8 months Daily Allied 
professional 
Social worker 
 
F 7 years Every few 
months 
Allied 
professional 
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Table 3. Themes, subthemes, and associated initial open codes 
Major 
theme 
Subtheme Initial open codes (subcodes in brackets) from which the 
themes derived  
The 
transition 
 
Recognition Identifying the transition 
Impact of the transition on patient (denial) 
Support provided to patients (written information) 
 Communication 
 
Discussing the transition 
Impact of the transition on patient (denial, DMAs, family, 
work) 
Support provided to patients (written information)  
Providing 
support  
 
Challenging 
aspects of patient 
care  
Hardest to manage symptom (cognitive or psychological, 
fatigue) 
Impact of the transition on patient (denial, DMAs, family, 
work)  
Self-management 
Support provided to patients (group support, Internet, 
signposting) 
Symptoms reported (cognitive, fatigue, mobility, mood, 
pain)  
 Working with 
others 
Team member roles 
 
 Service constraints 
 
Support provided to patients (ways to improve support) 
 Carer support 
 
Supporting carers 
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